CLDF Title
Home | Contact Us | Bookmark
NASH HCC
Centers of Educational Expertise  
Live CME Events Webcasts Slide Library Abstract Library CLDF 2019 Year in Review Conference Highlights
 
Back  
 
Reuters Health Information: Too much fructose disrupts intestinal barrier in mice, leading to liver damage

Too much fructose disrupts intestinal barrier in mice, leading to liver damage

Last Updated: 2020-09-03

By Marilynn Larkin

NEW YORK (Reuters Health) - A mouse study of fatty liver disease suggests that excessive fructose consumption disrupts the intestinal barrier, allowing endotoxins to leak out into the liver, thereby triggering cytokine production and conversion of fructose and glucose into fatty acid deposits. The process can set the stage for nonalcoholic fatty liver disease (NAFLD).

"As far as high-fructose corn syrup (HFCS) and other high-fructose foods consumed by humans, I think our studies suggest that only excessive, high-end (i.e., 90th percentile and above) fructose consumption is worrisome," Dr. Michael Karin of the University of California, San Diego told Reuters Health by email. "Occasional drinking of HFCS-containing soft drinks or processed food and moderate consumption of dried fruits may not lead to barrier deterioration, as observed after high-end fructose consumption."

"Therefore, clinicians need to caution their patients about excessive fructose consumption, such as a six-pack of soda a day plus pizza or other processed foods and sweets," he said. "As such, the eating habits of American children and teenagers are probably more of a concern than those of most adults".

The researchers explain in Nature Metabolism that benign hepatosteatosis progresses to non-alcoholic steatohepatitis (NASH, a severe manifestation of NAFLD) on stress and inflammation. Fructose has been proposed as a key macronutrient that increases both hepatosteatosis and NASH risk.

Working in mice, the team uncovered mechanisms by which excessive fructose may trigger these liver conditions. They found that excessive fructose intake causes intestinal-barrier deterioration (so-called "leaky gut"), resulting in endotoxemia, a chronic inflammatory condition that has been documented in both animals and pediatric NAFLD patients. When the leaked endotoxins reach the liver, they provoke increased production of inflammatory cytokines, stimulating the conversion of fructose and glucose into fatty acid deposits.

Notably, short-term high-fructose feeding did not alter intestinal barrier permeability; similarly, when fructose intake was reduced, the mice did not demonstrate any adverse effects. This suggests, as Dr. Karin noted, that only excessive, long-term fructose consumption might be a health risk. Further, antibiotic treatment reduced much of the damage to the intestinal barrier.

Dr. Kathleen Viveiros, a specialist in gastroenterology, hepatology and endoscopy at Brigham and Women's Hospital in Boston commented in an email that the findings seem feasible and "outline several mechanisms by which the pathway of hepatic steatosis and steatohepatitis could occur via fructose consumption."

That said, she told Reuters Health, "In mouse models, there was evidence that fructose induces barrier deterioration and intestinal epithelial endoplasmic reticulum stress. The (authors) showed that with administration of an antibiotic cocktail, the effect of increased permeability of the colon wall could be prevented. The gut microbiome in mouse models is different than in humans and quite complex. This finding is interesting but would require additional and continued study in humans."

"Fructose is found in sodas and many beverages - so high-yield dietary advice for clinicians counseling patients is to eliminate these items from daily consumption," she said. "However, fructose is present in many, many products - even those that are not considered 'sweet' - for example, sliced bread, cereals, etc."

"Clinicians who care for patients with NAFLD should try to counsel them on the importance of reading labels and avoiding foods with added sugars or sugars in the top of the ingredient list. Limiting these foods will help with insulin resistance, which contributes to NAFLD," she said. "In addition, clinicians should continue to encourage patients to eat whole foods whenever possible (vegetables, fruits, dairy products, eggs, meats, fish, poultry) and limit sugary, processed foods and beverages as much as they can."

SOURCE: https://go.nature.com/3hXVL4W Nature Metabolism, online August 24, 2020.

 
 
 
 
                               
 
HEPATITIS
HBV
HCV
HDV
 
 
HCC
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HRS
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
THROMBOCYTOPENIA
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
2019 GI Fellow Board of Advisors
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2020 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.